Erratum to Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer

Cancer Biol Med. 2019 Nov;16(4):836. doi: 10.20892/j.issn.2095-3941.2019.0401.

Yuxiang Wang^{1

2}, Xian Li¹, Xueling Liu^{1

2}, Yi Chen^{2

3}, Chunhao Yang⁴, Cun Tan⁴, Bobo Wang¹, Yiming Sun^{2

3}, Xi Zhang¹, Yinglei Gao^{2

3}, Jian Ding^{2

3}, Linghua Meng^{1

2}

¹ Division of Anti-Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
² University of Chinese Academy of Sciences, Beijing 100049, China.
³ Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
⁴ Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200120, China.

No abstract available